Daniel Avery is a Data Analyst with the China Kadoorie Biobank at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford. He graduated with an MSc in Research Methods from the University of Bristol before working for a number of companies in the retail sector performing data management roles. He is responsible for helping develop and manage the CKB database, ensuring the research team and collaborators have access to reliable and high quality data.
His primary duties include:
Developing and maintaining several of the tools used for automatic generation of datasets, as well as tools used for building and testing new data releases.
Acting as a knowledge bank for in-house researchers, about how data was gathered and managed, as well as known pitfalls or challenges associated with each data source.
Importing, cleaning and standardising information from sources as diverse as Health Insurance agencies, meteorological stations, urinalysis devices and genetic assays.
Generally trying to make the lives of CKB researchers easier.
The role of NMR-based circulating metabolic biomarkers in development and risk prediction of new onset type 2 diabetes.
Bragg F. et al, (2022), Sci Rep, 12
Tobacco smoking and solid fuels for cooking and risk of liver cancer: A prospective cohort study of 0.5 million Chinese adults.
Wen Q. et al, (2022), Int J Cancer, 151, 181 - 190
Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults.
Bragg F. et al, (2022), Diabetes Care, 45, 477 - 480
Liver biomarkers, genetic and lifestyle risk factors in relation to risk of cardiovascular disease in Chinese.
Wang X. et al, (2022), Front Cardiovasc Med, 9
Systemic inflammation is associated with incident stroke and heart disease in East Asians.
Karim MA. et al, (2020), Sci Rep, 10